Drug
Leo32731
Leo32731: highest development phase Phase 1, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO32731 NCT02126371 | Phase 1 | Psoriasis Vulgaris |
Latest
No recent events.
Follow Leo32731 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.